Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS
Von Fleischer V et al, erschienen in „Mult Scler“ (Vol. 24, Nr. 5, April 2018)
Von Fleischer V et al, erschienen in „Mult Scler“ (Vol. 24, Nr. 5, April 2018)